Canada methylphenidate 20 mg
INDICATIONS & USAGE: more than 7 weeks, has not been systematically evaluated...no single diagnostic test...inattentive symptoms that caused impairment and were present before age 7...treatment of Attention Deficit Hyperactivity Disorder (ADHD)...given cautiously to patients with a history of drug dependence or alcoholism...
round white APO SR 20
round white APO SR 20
Related Pills
24 HR dexmethylphenidate hydrochloride 15 MG Extended Release Oral Capsule
lannett company, inc.
methylphenidate hydrochloride 36 mg
alvogen inc.
dexmethylphenidate hydrochloride tablet
sun pharmaceutical industries, inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
Comments
4 months ago - Friday, Jul 12, 2024, 3:08 pm
Canada methylphenidate 20 mg [round white APO SR 20] https://www.medbroadcast.com/drug/getdrug/apo-methylphenidate-sr